UroGen Pharma
URGN
URGN
92 hedge funds and large institutions have $237M invested in UroGen Pharma in 2021 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 25 increasing their positions, 24 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
2% more call options, than puts
Call options by funds: $1.46M | Put options by funds: $1.44M
0.24% more ownership
Funds ownership: 62.75% → 63% (+0.24%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
92
Holding in Top 10
1
Calls
$1.46M
Puts
$1.44M
Top Buyers
| 1 | +$14.4M | |
| 2 | +$12.6M | |
| 3 | +$1.93M | |
| 4 |
HP
HealthInvest Partners
Stockholm,
Sweden
|
+$1.26M |
| 5 |
HCM
Horton Capital Management
Philadelphia,
Pennsylvania
|
+$953K |
Top Sellers
| 1 | -$18M | |
| 2 | -$6.16M | |
| 3 | -$1.55M | |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$1.21M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$892K |